$INO: Inovio Pharmaceuticals Prices $65.0 Million Convertible Senior …

Date: Thursday, February 14th, 2019

Stock(s) mentioned:

Source: PRNewswire (https://www.prnewswire.com)

Summary: 14, 2019 /PRNewswire/ — Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the pricing of its offering of $65.0 million aggregate principal amount of …

Full article address: https://www.prnewswire.com/news-releases/inovio-pharmaceuticals-prices-65-0-million-convertible-senior-notes-offering-300795643.html

Related News:

$NVAX $INO: Better Buy: Novavax vs. Inovio Pharmaceuticals

$MASI $INO $QGEN $CNMD: QIAGEN Partners Inovio to Develop Companion Diagnostics

$QGEN $INO: Qiagen teams up with Inovio to develop liquid biopsy companion …

$INO $QGEN: Inovio and QIAGEN Establish Collaboration to Develop Diagnostic …

$INO: Inovio and Plumbline Life Sciences Establish Animal Health …

$AZN $SNY $INO $REGN: Inovio (INO) Q1 Earnings & Revenues Fall Short of Estimates

$INO: What You’ll Want to Know About Inovio Pharmaceuticals’ Q1 …

$INO: Inovio Pharmaceuticals, Inc. (INO) CEO Joseph Kim on Q1 2019 …

$INO: Inovio Pharmaceuticals Inc (INO) Q1 2019 Earnings Call Transcript

$INO: Is Inovio Pharmaceuticals, Inc.’s (NASDAQ:INO) CEO Pay Justified?

$HZNP $INO $GNMSF $ACRX: What’s in the Cards for AcelRx (ACRX) This Earnings Season?

Latest News:

$AXJO $GOOGL $DXY: Asia markets set to open subdued with US-China trade negotiations said to hit a roadblock

$SPMO $SPX: There’s something strange going on with momentum stocks

$QD: Qudian’s Earnings Outlook

$QFIN: 360 Finance: A Unique ‘Tech-Giant Backed’ Fintech Opportunity

$PINS $TWTR $SNAP $FB: It was Pinterest’s full-year guidance that tripped the stock up

$MCD $KO: How to Set Up Your Children for Life

$JPM $AAPL $AMZN: JPMorgan Chase, Health Care And The ‘New’ Modern Corporation

$QD: Qudian Q1 2019 Earnings Preview

$IGT: International Game Technology PLC Q1 2019 Earnings Preview

$KMI $OPK: Notable Insider Buys This Past Week: Coty, Symantec and More

$TSN: African Swine Fever: An Opportunity For Tyson Foods